Home Other Building Blocks 1210935-33-3
1210935-33-3,MFCD17015956
Catalog No.:AA007P6D

1210935-33-3 | (R)-3-(Hydroxymethyl)-1-methylpyrrolidine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$26.00   $18.00
- +
500mg
95%
in stock  
$47.00   $33.00
- +
1g
95%
in stock  
$63.00   $45.00
- +
5g
98%
in stock  
$184.00   $129.00
- +
10g
95%
in stock  
$354.00   $248.00
- +
25g
98%
in stock  
$613.00   $429.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007P6D
Chemical Name:
(R)-3-(Hydroxymethyl)-1-methylpyrrolidine
CAS Number:
1210935-33-3
Molecular Formula:
C6H13NO
Molecular Weight:
115.1735
MDL Number:
MFCD17015956
SMILES:
OC[C@@H]1CCN(C1)C
Properties
Computed Properties
 
Complexity:
74.9  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  

Downstream Synthesis Route
1210935-33-3    1211914-14-5    536-74-3    76089-01-5   
C22H22N4O 
 
C22H22N4O 

[1]Lee,Sang-Bum;Park,YoungIn;Dong,Mi-Sook;Gong,Young-Dae[BioorganicandMedicinalChemistryLetters,2010,vol.20,#19,p.5900-5904]

1210935-33-3   
ethyl(2R)-2-(5Sa)-5-(3-chloro-4-hydroxy-2-methylphenyl)-6-(4-fluorophenyl)thieno2,3-dpyrimidin-4-yloxy-3-2-(pyrazin-2-ylmethoxy)phenylpropanoate 
 
C41H39ClFN5O5S 

[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;SERVIERMONDE-WO2015/97123,2015,A1Locationinpatent:Page/Pagecolumn259;260

[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1Locationinpatent:Paragraph0755

1210935-33-3   
tert-butyl2-(cyanomethyl)-4-2-methylsulfinyl-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazine-1-carboxylate 
 
tert-butyl2-(cyanomethyl)-4-2-(3R)-1-methylpyrrolidin-3-ylmethoxy-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazine-1-carboxylate 

[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1Locationinpatent:Paragraph0742

[2]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.;PFIZERINC-US2019/144444,2019,A1Locationinpatent:Paragraph1157-1158

1210935-33-3   
2-4-2-(3R)-1-methylpyrrolidin-3-ylmethoxy-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazin-2-ylacetonitriletrifluoroaceticacid 

[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1210935-33-3 Molecular Formula|1210935-33-3 MDL|1210935-33-3 SMILES|1210935-33-3 (R)-3-(Hydroxymethyl)-1-methylpyrrolidine |Heterocyclic_Building_Blocks